上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。
Pulsatilla saponin D (Synonyms: SB365; Hederacolchiside A) 纯度: 98.47%
Pulsatilla saponin D (SB365) 可从 Pulsatilla koreana Nakai 根部分离得到,具有抗癌活性。
Pulsatilla saponin D Chemical Structure
CAS No. : 68027-15-6
规格 | 价格 | 是否有货 | 数量 |
---|---|---|---|
10 mM * 1 mL in DMSO | ¥3977 | In-stock | |
5 mg | ¥1980 | In-stock | |
10 mg | 询价 | ||
50 mg | 询价 |
* Please select Quantity before adding items.
Pulsatilla saponin D 相关产品
•相关化合物库:
- Natural Product Library Plus
- Bioactive Compound Library Plus
- Apoptosis Compound Library
- Natural Product Library
- Anti-Cancer Compound Library
- Glycoside Compound Library
- Terpenoids Library
- Traditional Chinese Medicine Monomer Library
- Anti-Lung Cancer Compound Library
- Anti-Pancreatic Cancer Compound Library
生物活性 |
Pulsatilla saponin D (SB365), isolated from the root of Pulsatilla koreana Nakai, is an anti-tumor agent[1][2][3][4]. |
||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
体外研究 (In Vitro) |
Pulsatilla saponin D (SB365) shows apoptotic effect accompanied by increased evidence of cleaved caspase-3 and poly (ADP ribose) polymerase[1]. 上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only. Cell Cytotoxicity Assay[4]
|
||||||||||||||||
体内研究 (In Vivo) |
Pulsatilla saponin D (6.4 mg/kg) exhibits anti-tumor activity in Lewis lung carcinoma model[4]. 上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.
|
||||||||||||||||
分子量 |
913.10 |
||||||||||||||||
Formula |
C47H76O17 |
||||||||||||||||
CAS 号 |
68027-15-6 |
||||||||||||||||
中文名称 |
白头翁皂苷 D |
||||||||||||||||
运输条件 |
Room temperature in continental US; may vary elsewhere. |
||||||||||||||||
储存方式 |
4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) |
||||||||||||||||
溶解性数据 |
In Vitro:
DMSO : ≥ 39 mg/mL (42.71 mM) * “≥” means soluble, but saturation unknown. 配制储备液
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo:
请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
|
||||||||||||||||
参考文献 |
|
所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务